Day 1 - Saturday, 15 October 2016
Meeting category
Date(s)
15 Oct 2016 - 17 Oct 2016
Location
Chicago,
United States
Platinum Level Support
Sponsor logos
International Workshop on HIV Transmission 2016
Related Enduring Materials
Enduring Materials
Session 1: The role of the human microbiome -
Chairs
Bonnie Mathieson, PhD
NIH, USA
Bacteria building babies: the role of the microbiome in infant immune development
Microbial and host mucosal factors in the genital tract modulating PrEP efficacy and HIV infection risk in women
Female-to-Male transmitted/ founder HIV-1 are less susceptible to inactivation by vaginal microbiota acid metabolites than non-transmitted strains
G. Tachedjian
Abstract: O_01
HIV-infected macrophages can establish de novo infection after vaginal exposure
S. Patro
Abstract: O_02
Unique phenotypic properties influence HIV-1 mucosal transmission fitness
K. Klein
Abstract: O_03
Pre-exposure prophylaxis with EFdA offers strong protection against high dose mucosal HIV challenges
M. Kovarova
Abstract: O_04
Session 2: Transmission of drug resistance viruses -
Chairs
Identifying growing clusters of recent, rapid HIV transmission to target prevention
AM. France
Abstract: O_05
Increased ability of molecular surveillance data to describe HIV transmission in the United States
AM. France
Abstract: O_06
On the distribution of multivariant HIV-1 transmission events
J. Carlson
Abstract: O_07
High rates of transmission of drug-resistant HIV in Aruba resulting in reduced susceptibility to the WHO recommended first-line regimen
A. Wensing
Abstract: O_08
Extensive intra-host HIV diversity associated with drug resistance and superinfection in U.S. national surveillance sequences
J. Johnson
Abstract: O_09
Day 2 - Sunday, 16 October 2016
Session 3: Broad neutralizing AB’s - Pediatric studies -
Chairs
Maureen Goodenow, PhD
NIH, USA
Study of early development of broadly neutralizing antibodies in HIV-1-infected infants
Cassandra Simonich, MD/PhD Candidate
University of Washington Medical Scientist Training Program, USA
The fine specificity and autologous virus neutralization potency of maternal antibodies that predict reduced HIV-1 mother to child transmission
IMPAACT 1112: Passive immunization safety and PK of VRC01 in infants
Coleen Cunningham, MD
Duke Department of Pediatrics, USA
Session 4: Abstract driven session -
Chairs
The Role of TAF in PrEP
Deciphering the specificity of antibody profiles in patients that control HIV
J. Klingler
Abstract: O_11
The role of gut homing receptor a4ß7 in HIV pathogenesis and transmission- a prospective cohort study
A. Sivro
Abstract: O_12
Transmitted HLA pre-adapted polymorphisms in the gag protein dictates viral evolution in the new host
D. Monaco
Abstract: O_10
HIV care and engagement: Demographics and risk factors associated with retention and viral suppression in Chicago, IL
E. Almirol
Abstract: PP_16
Patterns of anal sex practices and its contribution to heterosexually acquired HIV infections among high-risk women in the US
J. Elmes
Abstract: PP_17
Session 5: “Very early” acute cohorts -
Chairs
Studies in early acute infection and implications for transmission and cure
Gender Differences in Transmission of HIV-1 Viral Variants and Their Impact on Early Immune Activation
E. El-Badry
Abstract: O_13
Impact of targeted pre-exposure prophylaxis strategies for men who have sex with men in the United States
R. Elion
Abstract: O_14
Introducing dolutegravir into South Africa will eliminate resistance
K. Sharp
Abstract: O_15
Session 6: Prevention after the pill - Long acting formulation for the prevention of HIV: From design to delivery -
Chairs
Yasmin Halima, MPH
EQUIP/ Right to Care, South Africa
Research update: drug development
Design engineering of vaginal rings: Drug release and HIV transmission
Patrick Kiser, PhD
Northwestern University, USA
Clinical development of a multipurpose prevention technology
Gustavo Doncel, MD, PhD
CONRAD, USA
Overview
The very successful 11th edition of the International Workshop on HIV Transmission took place on 15 and 16 October 2016 in Chicago, IL, USA.
The Organizing Committee would like to thank all invited speakers and participants for their contribution to this workshop!
We would like to thank our supporters ViiV Healthcare, Gilead Sciences and Siemens Healthnieers for making this event possible.
General Information
Meeting Objectives
This meeting aims to:
- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV;
- Provide a forum to discuss the various aspects of the transmission of HIV.
- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV;
- Provide a forum to discuss the various aspects of the transmission of HIV.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the latest research on mucosal transmission of virus particles;
- Outline the different approaches to identify the spread of (drug-resistant) HIV variants;
- Reflect on clinical achievements in the prevention of HIV transmission.
- Describe the latest research on mucosal transmission of virus particles;
- Outline the different approaches to identify the spread of (drug-resistant) HIV variants;
- Reflect on clinical achievements in the prevention of HIV transmission.
Practical Information
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Support
Language
Related Programs
